Log in to save to my catalogue

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2194528557

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Hepatocellular carcinoma is the third leading cause of deaths from cancer worldwide. Infection with the hepatitis B virus is one of the leading risk factors for developing hepatocellular carcinoma, particularly in East Asia
1
. Although surgical treatment may be effective in the early stages, the five-year overall rate of survival after devel...

Alternative Titles

Full title

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2194528557

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2194528557

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-019-0987-8

How to access this item